Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

Clinical trial NCT06574984 · COMPLETED

Trial details

NCT number: NCT06574984
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Bleeding Disorder Haemophilia A

Start date: 2024-11-10
Primary completion: 2025-11-04
Enrollment: 329

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.